Clinical Trial Update: A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS [Phase 4]

View source ↗

Summary

The document notes the completion of a Phase IV clinical trial evaluating the effects of pramipexole on Restless Legs Syndrome symptoms and sleep disturbance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Mirapex (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Restless Legs Syndrome | Phase 4 | Status: COMPLETED